Federation des caisses Desjardins du Quebec’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.21M Sell
251,255
-23,657
-9% -$396K 0.02% 434
2025
Q1
$4.23M Buy
274,912
+4,416
+2% +$67.9K 0.02% 393
2024
Q4
$5.96M Buy
270,496
+15,239
+6% +$336K 0.03% 311
2024
Q3
$4.6M Sell
255,257
-10,198
-4% -$184K 0.02% 365
2024
Q2
$4.31M Buy
265,455
+130,363
+96% +$2.12M 0.02% 360
2024
Q1
$1.79M Buy
135,092
+49,475
+58% +$654K 0.01% 552
2023
Q4
$894K Sell
85,617
-5,990
-7% -$62.5K 0.01% 669
2023
Q3
$934K Sell
91,607
-6,196
-6% -$63.2K 0.01% 602
2023
Q2
$736K Buy
97,803
+6,527
+7% +$49.1K 0.01% 682
2023
Q1
$808K Sell
91,276
-17,419
-16% -$154K 0.01% 649
2022
Q4
$991K Sell
108,695
-974
-0.9% -$8.88K 0.01% 570
2022
Q3
$885K Sell
109,669
-2,400
-2% -$19.4K 0.01% 608
2022
Q2
$843K Buy
112,069
+22,744
+25% +$171K 0.01% 642
2022
Q1
$839K Sell
89,325
-2,779
-3% -$26.1K 0.01% 699
2021
Q4
$738K Sell
92,104
-998
-1% -$7.99K 0.01% 743
2021
Q3
$907K Sell
93,102
-3,055
-3% -$29.7K 0.01% 718
2021
Q2
$952K Sell
96,157
-9,749
-9% -$96.5K 0.01% 721
2021
Q1
$1.22M Buy
105,906
+4,324
+4% +$49.9K 0.01% 621
2020
Q4
$980K Sell
101,582
-170,937
-63% -$1.65M 0.01% 639
2020
Q3
$2.46M Buy
272,519
+13,709
+5% +$124K 0.03% 346
2020
Q2
$3.19M Sell
258,810
-209,557
-45% -$2.58M 0.05% 286
2020
Q1
$4.21M Sell
468,367
-17,377
-4% -$156K 0.07% 198
2019
Q4
$4.76M Buy
485,744
+2,199
+0.5% +$21.6K 0.07% 228
2019
Q3
$3.33M Buy
483,545
+106,341
+28% +$732K 0.05% 287
2019
Q2
$3.48M Buy
377,204
+150,839
+67% +$1.39M 0.05% 283
2019
Q1
$3.55M Buy
226,365
+22,652
+11% +$355K 0.05% 267
2018
Q4
$3.14M Buy
203,713
+11,115
+6% +$171K 0.05% 285
2018
Q3
$4.15M Sell
192,598
-2,404
-1% -$51.8K 0.06% 258
2018
Q2
$4.74M Sell
195,002
-44,489
-19% -$1.08M 0.07% 242
2018
Q1
$4.09M Buy
239,491
+33,287
+16% +$569K 0.06% 261
2017
Q4
$3.91M Buy
206,204
+6,548
+3% +$124K 0.06% 265
2017
Q3
$3.51M Buy
199,656
+31,763
+19% +$559K 0.06% 271
2017
Q2
$5.58M Buy
167,893
+5,260
+3% +$175K 0.09% 201
2017
Q1
$5.22M Buy
+162,633
New +$5.22M 0.1% 181